AI Science Tracker
EN

ECG models identify concurrent high-risk imaging features in hypertrophic cardiomyopathy

Johns Hopkins University; Tufts Medical Center; Amrita Institute of Medical Sciences · 26 Jan 2024 · medicine

Discovery

ECG models identify concurrent high-risk imaging features in hypertrophic cardiomyopathy

Source check: Source checked. Not independent scientific confirmation.

Finding: A pretrained variational-autoencoder ECG representation supported classifiers for four imaging findings in hypertrophic cardiomyopathy. In233 patients at another centre, ROC areas ranged from0.68 for extensive enhancement to0.91 for apical aneurysm, with only one aneurysm-positive patient. This is retrospective reference-label evaluation, not a demonstration that imaging can safely be omitted.

Technology: Variational autoencoder; dense neural-network classifiers

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A VAE pretrained on88105 ECGs provides24 latent features to learned classifiers, alongside age, sex and heart rate, linking electrical patterns to contemporaneous imaging labels.
Test and result
Tufts1930 patients were partitioned1544 development and386 holdout, followed by233 Amrita patients. Endpoints were reduced ejection fraction, extreme wall thickness, apical aneurysm and extensive late gadolinium enhancement.
Limitation / still unknown
Only one external aneurysm-positive case makes that endpoint highly uncertain. CMR labels were available in selected1584/1930 development-site and104/233 external patients. Hypothetical imaging savings combined development and evaluation cases; they are not prospective savings or safety evidence. A linked editorial is authenticated as Comment/Editorial, not a correction; its full body was not reviewed. No clinical-benefit or causal interpretation is established.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11272903/ · https://doi.org/10.1016/j.hrthm.2024.01.031

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 21 Nov 2026. Review scope: Actual relevant primary computational/clinical Methods and high-level Results read; no operational biological protocols inspected.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.

Related catalog entries

Links use documented relationships where available, plus shared catalog context. A shared topic or model family does not establish a scientific dependency.